Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
一项针对激素敏感型寡转移复发前列腺癌的随机II期临床试验：立体定向消融放疗联合度伐利尤单抗（POSTCARD GETUG P13）：研究方案
期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2023.100613
Rogé, Maximilien; Pointreau, Yoann; Sargos, Paul; Meyer, Emmanuel; Schick, Ulrike; Hasbini, Ali; Rio, Emmanuel; Bera, Guillaume; Ruffier, Amandine; Quivrin, Magali; Chasseray, Mathieu; Latorzeff, Igor; Martin, Etienne; Guimas, Valentine; Pommier, Pascal; Leroy, Thomas; Ronchin, Philippe; Lepinoy, Alexis; Grand, Audrey; Cartier, Lysian; Didas, Ossama; Denis, Fabrice; Libois, Vincent; Blanc-Lapierre, Audrey; Supiot, Stéphane
